| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 116, 2152-2159, Copyright © 1985 by Endocrine Society
ARTICLES |
JR Dave, LE Eiden and RL Eskay
Specific binding sites for rat corticotropin-releasing factor (rCRF) are present in rat adrenal medulla, ventral prostate, spleen, liver, kidney, and testis and bovine chromaffin cells in culture. Maximal binding of [125I]rCRF occurred within 25 min at 4 C and was saturable. Scatchard analysis of rCRF binding to rat adrenal membranes and bovine chromaffin cells revealed the existence of two classes of binding sites. One class had a relatively higher apparent affinity and lower number of binding sites, whereas the other class had a relatively lower affinity and higher number of binding sites. CRF induced a dose-related increase in rat adrenal membrane adenylate cyclase activity and cAMP levels in bovine chromaffin cells. Nanomolar concentrations of rCRF maximally stimulated adenylate cyclase activity in rat adrenal membranes and maximally increased cAMP levels in bovine chromaffin cells to 86% and 130% above control values, respectively. The demonstration of specific CRF-binding sites in a variety of peripheral tissues and the finding that activation of specific CRF-binding sites in adrenal tissue stimulates the adenylate cyclase-cAMP system suggest that CRF may have an important regulatory role in various peripheral tissues.
This article has been cited by other articles:
![]() |
M. O Huising, L. M van der Aa, J. R Metz, A. de Fatima Mazon, B M L. V.-v. Kemenade, and G. Flik Corticotropin-releasing factor (CRF) and CRF-binding protein expression in and release from the head kidney of common carp: evolutionary conservation of the adrenal CRF system J. Endocrinol., June 1, 2007; 193(3): 349 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dermitzaki, C. Tsatsanis, V. Minas, E. Chatzaki, I. Charalampopoulos, M. Venihaki, A. Androulidaki, M. Lambropoulou, J. Spiess, E. Michalodimitrakis, et al. Corticotropin-Releasing Factor (CRF) and the Urocortins Differentially Regulate Catecholamine Secretion in Human and Rat Adrenals, in a CRF Receptor Type-Specific Manner Endocrinology, April 1, 2007; 148(4): 1524 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ikushima, M. Kanaoka, and S. Kojima Cutting Edge: Requirement for Growth Hormone-Releasing Hormone in the Development of Experimental Autoimmune Encephalomyelitis J. Immunol., September 15, 2003; 171(6): 2769 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Wang, L. Y. Tsai, and E. H. Y. Lee Corticotropin-Releasing Factor Produces a Protein Synthesis-Dependent Long-Lasting Potentiation in Dentate Gyrus Neurons J Neurophysiol, January 1, 2000; 83(1): 343 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Agnello, R. Bertini, S. Sacco, C. Meazza, P. Villa, and P. Ghezzi Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E757 - E762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Venihaki, K. Ain, E. Dermitzaki, A. Gravanis, and A. N. Margioris KAT45, a Noradrenergic Human Pheochromocytoma Cell Line Producing Corticotropin-Releasing Hormone Endocrinology, February 1, 1998; 139(2): 713 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gnessi, A. Fabbri, and G. Spera Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment Endocr. Rev., August 1, 1997; 18(4): 541 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Venihaki, A. Gravanis, and A. N. Margioris Comparative Study between Normal Rat Chromaffin and PC12 Rat Pheochromocytoma Cells: Production and Effects of Corticotropin-Releasing Hormone Endocrinology, February 1, 1997; 138(2): 698 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Karalis, H Sano, J Redwine, S Listwak, R. Wilder, and G. Chrousos Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo Science, October 18, 1991; 254(5030): 421 - 423. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |